ECM
AGN

Everence Capital Management’s Allergan plc AGN Stock Holding History

Everence Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,100
Closed -$1.26M – 679
2020
Q1 		$1.26M Hold
7,100
– – 0.18% 99
2019
Q4 		$1.36M Buy
7,100
+1,310
+23% +$236K 0.2% 106
2019
Q3 		$974K Hold
5,790
– – 0.16% 135
2019
Q2 		$969K Hold
5,790
– – 0.16% 133
2019
Q1 		$848K Buy
+5,790
New +$839K 0.15% 145
2016
Q1 		– Sell
-8,046
Closed -$2.51M – 298
2015
Q4 		$2.51M Buy
8,046
+602
+8% +$179K 0.81% 29
2015
Q3 		$2.02M Hold
7,444
– – 0.7% 40
2015
Q2 		$2.26M Buy
7,444
+2,948
+66% +$879K 0.73% 38
2015
Q1 		$1.31M Hold
4,496
– – 0.44% 59
2014
Q4 		$1.16M Buy
4,496
+779
+21% +$195K 0.4% 73
2014
Q3 		$844K Buy
3,717
+494
+15% +$111K 0.31% 108
2014
Q2 		$719K Hold
3,223
– – 0.27% 127
2014
Q1 		$663K Hold
3,223
– – 0.26% 128
2013
Q4 		$541K Buy
+3,223
New +$504K 0.22% 142

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Everence Capital Management's AGN Position: Q2 2020 in Review

Everence Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,100 shares — an estimated $1.26M sold.

Everence Capital Management first reported a position in AGN in Q4 2013 and held it in 14 quarters. The position peaked at $2.51M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Everence Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Everence Capital Management sold 7,100 Allergan plc shares in Q2 2020, an estimated $1.26M.
  • Everence Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 14 quarters.
  • Everence Capital Management's Allergan plc position peaked at $2.51M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Everence Capital Management's 13F filing for Q2 2020, filed 7 Jul 2020.